TPST vs. TENX

In the year-to-date period, TPST achieves a 3.10% return, which is significantly lower than TENX's 9.05% return. Both investments have delivered pretty close results over the past 10 years, with TPST having a -61.05% annualized return and TENX not far behind at -61.85%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tempest Therapeutics, Inc. (TPST) and Tenax Therapeutics, Inc. (TENX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TPST Sharpe Ratio is -0.79, which is lower than the TENX Sharpe Ratio of 1.02. The chart below compares the historical Sharpe Ratios of TPST and TENX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TPST nor TENX has paid dividends to shareholders.

The maximum TPST drawdown since its inception was -100.00%, roughly equal to the maximum TENX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TPST and TENX. For additional features, visit the drawdowns tool.

The current volatility for Tempest Therapeutics, Inc. (TPST) is 12.75%, while Tenax Therapeutics, Inc. (TENX) has a volatility of 22.16%. This indicates that TPST experiences smaller price fluctuations and is considered to be less risky than TENX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Tempest Therapeutics, Inc. and Tenax Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.